Literature DB >> 36198636

A Case of Adalimumab-Induced Psoriasiform Dermatitis in an Ankylosing Spondylitis Patient: Unusual Progression after Adalimumab Retreatment.

Ji Ha Yoon1, Joon Woo Jung1, Eun Joo Park1, Kwang Joong Kim1, Kwang Ho Kim2.   

Abstract

Entities:  

Year:  2022        PMID： 36198636      PMCID： PMC9561303          DOI： 10.5021/ad.20.094

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   0.722


× No keyword cloud information.
  5 in total

1.  Histologic comparison of tumor necrosis factor-α inhibitor-induced psoriasis and psoriasis vulgaris.

Authors:  Jeffrey Zhu Hu; Steven D Billings; Di Yan; Anthony Patrick Fernandez
Journal:  J Am Acad Dermatol       Date:  2020-01-11       Impact factor: 11.527

Review 2.  Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.

Authors:  Lluís Puig; Caridad E Morales-Múnera; Anna López-Ferrer; Carme Geli
Journal:  Dermatology       Date:  2012-08-10       Impact factor: 5.366

Review 3.  Tumor necrosis factor-α inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience.

Authors:  Gabrielle Brown; Eva Wang; Argentina Leon; Monica Huynh; Mackenzie Wehner; Rebecca Matro; Eleni Linos; Wilson Liao; Anna Haemel
Journal:  J Am Acad Dermatol       Date:  2016-10-05       Impact factor: 11.527

Review 4.  Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases.

Authors:  Justin M Ko; Alice B Gottlieb; Joseph F Kerbleski
Journal:  J Dermatolog Treat       Date:  2009       Impact factor: 3.359

5.  TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management.

Authors:  Sara Jiayang Li; Lourdes M Perez-Chada; Joseph F Merola
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2018-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.